Evidity Health Capital

Evidity Health Capital is a late-stage venture capital and growth equity firm focused on medical devices, in vitro diagnostics, and digital health. It was founded in 2014 as Canepa Healthcare and rebranded in 2019, emphasizing private medical technology companies with commercialized products that need growth capital to reach profitability. The firm pursues a value-focused, evidence-based approach and actively shapes business plans and teams to drive successful exits, prioritizing medtech companies with US regulatory clearance and typically investing at least $5 million. The investment focus spans venture capital and growth equity in medical technology, with a strong emphasis on market-ready innovations that deliver clinical and health economic value.